NCI has not yet decided whether it should add new requirements for
omics tests to its peer review process for investigator - initiated grants.
Not exact matches
Proteomics International Laboratories» partner
Omics Global Solutions launched PromarkerD, a predictive diagnostic
test for diabetic kidney disease.
IOM found many potential problems inherent in
tests based on
omics, which it defines as research that looks for patterns in large sets of molecules such as proteins, DNA, RNA, or metabolites.
The Institute of Medicine (IOM) report says that so - called «
omics»
tests — diagnostic tools based on molecular patterns — are highly prone to errors; it recommends they be rigorously validated before being used in clinical trials.
In order to dissect these defects, we utilize a unique approach including deep assessment of patient phenotype, clinical genetic
testing to identify underlying genetic contributions to these features, and the application of combinatorial functional
omics (transcriptome, metabolome, etc.) to uncover the pathological cellular states that result from these genetic changes.